Experimental Hematology
Volume 40, Issue 2 , Pages 155-165.e1 , February 2012

Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance

  • Dan Ran

      Affiliations

    • Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
    • ,
  • Mario Schubert

      Affiliations

    • Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
    • ,
  • Isabel Taubert

      Affiliations

    • Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
    • ,
  • Volker Eckstein

      Affiliations

    • Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
    • ,
  • Frauke Bellos

      Affiliations

    • Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
    • ,
  • Anna Jauch

      Affiliations

    • Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany
    • ,
  • Hui Chen

      Affiliations

    • Department of Maternal and Child Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China
    • ,
  • Thomas Bruckner

      Affiliations

    • Department of Biometry, University of Heidelberg, Heidelberg, Germany
    • ,
  • Rainer Saffrich

      Affiliations

    • Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
    • ,
  • Patrick Wuchter

      Affiliations

    • Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
    • ,
  • Anthony D. Ho

      Affiliations

    • Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
    • Corresponding Author InformationOffprint requests to: Anthony D. Ho, M.D., F.R.C.P.C., Department of Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany

Received 7 June 2011 ,Revised 14 October 2011 ,Accepted 14 October 2011.

References 

  1. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645–648
  2. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111
  3. Sutherland HJ, Blair A, Zapf RW. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood. 1996;87:4754–4761
  4. Jordan CT, Upchurch D, Szilvassy SJ, et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia. 2000;14:1777–1784
  5. Huntly BJ, Gilliland DG. Cancer biology: summing up cancer stem cells. Nature. 2005;435:1169–1170
  6. van Rhenen A, Feller N, Kelder A, et al. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res. 2005;11:6520–6527
  7. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–737
  8. Pearce DJ, Taussig D, Zibara K, et al. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. Blood. 2006;107:1166–1173
  9. Taussig DC, Vargaftig J, Miraki-Moud F, et al. Leukemia initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction. Blood. 2010;115:1976–1984
  10. Terwijn M, Feller N, van Rhenen A, et al. Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML. Eur J Cancer. 2009;45:1692–1699
  11. Terwijn M, Rutten AP, Kelder A, et al. Accurate detection of residual leukemic stem cells In remission bone marrow predicts relapse in acute myeloid leukemia patients. Blood (ASH Annual Meeting Abstracts). 2010;116:Abstract 759.
  12. Rosen JM, Jordan CT. The increasing complexity of the cancer stem cell paradigm. Science. 2009;324:1670–1673
  13. Capoccia BJ, Robson DL, Levac KD, et al. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood. 2009;113:5340–5351
  14. Hess DA, Wirthlin L, Craft TP, et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood. 2006;107:2162–2169
  15. Storms RW, Trujillo AP, Springer JB, et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A. 1999;96:9118–9123
  16. Gentry T, Foster S, Winstead L, Deibert E, Fiordalisi M, Balber A. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy. 2007;9:259–274
  17. Hess DA, Meyerrose TE, Wirthlin L, et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood. 2004;104:1648–1655
  18. Ran D, Schubert M, Pietsch L, et al. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes. Exp Hematol. 2009;37:1423–1434
  19. Schubert M, Herbert N, Taubert I, et al. Differential survival of AML subpopulations in NOD/SCID mice. Exp Hematol. 2011;39:250–263
  20. Punzel M, Zhang T, Liu D, Eckstein V, Ho AD. Functional analysis of initial cell divisions defines the subsequent fate of individual human CD34(+)CD38(-) cells. Exp Hematol. 2002;30:464–472
  21. Punzel M, Lui D, Zhang T, Eckstein V, Miesala K, Ho AD. The symmetry of initial divisions of human hematopoietic progenitors is altered only by the cellular microenvironment. Exp Hematol. 2003;31:339–347
  22. Levis M, Murphy KM, Pham R, et al. Internal tandem duplications of the FLT3 gene are present in leukemia stem cells. Blood. 2005;106:673–680
  23. Oostendorp RA, Audet J, Miller C, Eaves CJ. Cell division tracking and expansion of hematopoietic long-term repopulating cells. Leukemia. 1999;13:499–501
  24. Vitacolonna M, Schubert M, Herbert N, et al. Improved T and B cell recovery by the transfer of slowly dividing human hematopoietic stem cells. Leuk Res. 2010;34:622–630
  25. Young JC, Varma A, DiGiusto D, Backer MP. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood. 1996;87:545–556
  26. Pearce DJ, Taussig D, Simpson C, et al. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells. 2005;23:752–760
  27. Croker AK, Goodale D, Chu J, et al. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med. 2009;13:2236–2252
  28. Ma S, Chan KW, Lee TK, et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res. 2008;6:1146–1153
  29. Ucar D, Cogle CR, Zucali JR, et al. Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact. 2009;178:48–55
  30. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1:555–567
  31. Chu P, Clanton DJ, Snipas TS, et al. Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer. 2009;124:1312–1321
  32. Cheung AM, Wan TS, Leung JC, et al. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia. 2007;21:1423–1430
  33. Notta F, Mullighan CG, Wang JC, et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature. 2011;469:362–367
  34. Anderson K, Lutz C, van Delft FW, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature. 2011;469:356–361
  35. Goarden N, Marchi E, Atzberger A, et al. Coexistence of LMPP-like and GMP-like leukemia stem cells inacute myeloid leukemia. Cancer Cell. 2011;19:138–152
  36. Brandwein JM, Gupta V, Schuh AC, et al. Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy. Am J Hematol. 2008;83:54–58

PII: S0301-472X(11)00502-9

doi: 10.1016/j.exphem.2011.10.005

Experimental Hematology
Volume 40, Issue 2 , Pages 155-165.e1 , February 2012

Article Tools

* Image Usage & Resolution